SMAD2 and hepatocellular carcinoma: For example, HCC cell-derived Exo-miR-125b can directly target SMAD2 and downregulate its expression, further inhibiting TGF-β1-induced EMT and TGF-β1/SMAD pathway, thus suppressing the migration and invasive ability of HCC cells (20).